UnknownNot Applicable

Oral Postbiotics in Patients With Macular Atrophy

Spain10 participantsStarted 2020-12-01

Plain-language summary

A pilot study to evaluate the safety and efficacy of oral therapy with Postbiotics in patients with geographic atrophy secondary to age-related macular degeneration, myopia, or angioid streaks.

Who can participate

Age range55 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients with GA secondary to AMD, myopia or angioid streaks * with 12 months of previous follow-up, * and a known progression of \>0,20mm/year as per SQRT Exclusion Criteria: \- history of choroidal neovascularization in the study eye

What they're measuring

rate of growth of geographic atrophy (GA) as per SQRT (square roor transformation) of area of GA measured in FAF, (fundus autofluorescence)

Timeframe: 12 months

safety and tolerability

Timeframe: 12 months

Trial details

NCT IDNCT05391074

SponsorInstitut de la Macula y la Retina

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-12-01

View on ClinicalTrials.gov More Geographic Atrophy trials